IRIS Accounts Production v24.1.4.33 09380928 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh093809282023-01-31093809282024-01-31093809282023-02-012024-01-31093809282022-01-31093809282022-02-012023-01-31093809282023-01-3109380928ns15:EnglandWales2023-02-012024-01-3109380928ns14:PoundSterling2023-02-012024-01-3109380928ns10:Director12023-02-012024-01-3109380928ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3109380928ns10:SmallEntities2023-02-012024-01-3109380928ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3109380928ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3109380928ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3109380928ns10:FullAccounts2023-02-012024-01-3109380928ns10:Director22023-02-012024-01-3109380928ns10:CompanySecretary12023-02-012024-01-3109380928ns10:RegisteredOffice2023-02-012024-01-3109380928ns5:CurrentFinancialInstruments2024-01-3109380928ns5:CurrentFinancialInstruments2023-01-3109380928ns5:Non-currentFinancialInstruments2024-01-3109380928ns5:Non-currentFinancialInstruments2023-01-3109380928ns5:ShareCapital2024-01-3109380928ns5:ShareCapital2023-01-3109380928ns5:RetainedEarningsAccumulatedLosses2024-01-3109380928ns5:RetainedEarningsAccumulatedLosses2023-01-3109380928ns5:PlantMachinery2023-02-012024-01-3109380928ns5:PlantMachinery2023-01-3109380928ns5:PlantMachinery2024-01-3109380928ns5:PlantMachinery2023-01-3109380928ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-01-3109380928ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-02-012024-01-3109380928ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-01-3109380928ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-01-3109380928ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3109380928ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3109380928ns5:DeferredTaxation2023-01-3109380928ns5:DeferredTaxation2023-02-012024-01-3109380928ns5:DeferredTaxation2024-01-31
REGISTERED NUMBER: 09380928 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JANUARY 2024

FOR

J T GRIFFITHS MEDICAL LIMITED

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


J T GRIFFITHS MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2024







DIRECTORS: Dr J T Griffiths
Dr A G Griffiths





SECRETARY: Dr J T Griffiths





REGISTERED OFFICE: Larch House
Parklands Business Park
Denmead
Hampshire
PO7 6XP





REGISTERED NUMBER: 09380928 (England and Wales)





ACCOUNTANTS: Gibson Whitter
Chartered Accountants
and Chartered Tax Advisers
Larch House
Parklands Business Park
Denmead
Hampshire
PO7 6XP

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

BALANCE SHEET
31 JANUARY 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 77,379 46,100

CURRENT ASSETS
Debtors 5 490,004 39,081
Cash at bank 187,891 302,755
677,895 341,836
CREDITORS
Amounts falling due within one year 6 112,239 72,149
NET CURRENT ASSETS 565,656 269,687
TOTAL ASSETS LESS CURRENT
LIABILITIES

643,035

315,787

CREDITORS
Amounts falling due after more than one
year

7

(86,720

)

(37,393

)

PROVISIONS FOR LIABILITIES 9 (19,345 ) (11,525 )
NET ASSETS 536,970 266,869

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 536,870 266,769
536,970 266,869

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

BALANCE SHEET - continued
31 JANUARY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 21 October 2024 and were signed on its behalf by:





Dr J T Griffiths - Director


J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024

1. STATUTORY INFORMATION

J T Griffiths Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 February 2023 66,627
Additions 57,973
At 31 January 2024 124,600
DEPRECIATION
At 1 February 2023 20,527
Charge for year 26,694
At 31 January 2024 47,221
NET BOOK VALUE
At 31 January 2024 77,379
At 31 January 2023 46,100

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 February 2023 58,190
Additions 56,975
At 31 January 2024 115,165
DEPRECIATION
At 1 February 2023 14,548
Charge for year 25,154
At 31 January 2024 39,702
NET BOOK VALUE
At 31 January 2024 75,463
At 31 January 2023 43,642

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade debtors 25,077 4,557
Other debtors 464,927 34,524
490,004 39,081

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Hire purchase contracts 7,648 7,285
Taxation and social security 98,215 57,682
Other creditors 6,376 7,182
112,239 72,149

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.1.24 31.1.23
£    £   
Hire purchase contracts 86,720 37,393

8. SECURED DEBTS

The following secured debts are included within creditors:

31.1.24 31.1.23
£    £   
Hire purchase contracts 94,368 44,678

The hire purchase contracts are secured against the assets being financed.

9. PROVISIONS FOR LIABILITIES
31.1.24 31.1.23
£    £   
Deferred tax 19,345 11,525

Deferred
tax
£   
Balance at 1 February 2023 11,525
Utilised during year 7,820
Balance at 31 January 2024 19,345

10. RELATED PARTY TRANSACTIONS

At the year end the company owed the directors: £4,972 (31.1.23: £5,844).

Included within other debtors is an amount owed by a connected company £462,916 (31.1.23: £32,870)

11. ULTIMATE CONTROLLING PARTY

The controlling parties are Dr A G Colvin and Dr J T Griffiths by virtue of their shareholding.